jan 11, 2018 - FDA Commissioner, Scott Gottlieb,
M.D., announced the 2018 Strategic Policy
Roadmap. Part of the Roadmap is reducing
misuse and abuse of opioid drugs.
FDA announced that it is requiring
safety labeling changes for prescription cough
and cold medicines containing codeine or
hydrocodone. Additional safety measures also
added.
Added to timeline:
Opioids and the FDA
Date: